EGFR and HER2 mutation and gene amplification in non-small-cell lung cancer

被引：0
|
作者：
Toshihiko, Yokoyama
Kondo, Masashi
Goto, Yasuhiro
Fukui, Takayuki
Yoshioka, Hiromu
Yokoi, Kohei
Kondo, Yutaka
Osada, Hirotaka
Imaizumi, Kazuyoshi
Hasegawa, Yoshinori
Shimokata, Kaoru
Sekido, Yoshitaka
机构：
[1] Aichi Canc Ctr, Nagoya, Aichi, Japan
[2] Nagoya Univ, Dept Resp Med, Nagoya, Aichi, Japan
[3] Nagoya Univ, Dept Thorat Surg, Nagoya, Aichi, Japan
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4134
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EGFR mutations in non-small-cell lung cancer
    Hung, Jung-Jyh
    Jeng, Wen-Juei
    Hsu, Wen-Hu
    Liu, Jung-Sen
    Wu, Yu-Chung
    LANCET ONCOLOGY, 2010, 11 (05): : 412 - 413
  • [42] Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer
    Codony-Servat, Jordi
    Codony-Servat, Caries
    Cardona, Andres Felipe
    Gimenez-Capitan, Ana
    Drozdowskyj, Ana
    Berenguer, Ordi
    Paulina Bracht, Milan Wilhe Mina
    Ito, Masaoki
    Karachaliou, Niki
    Rosell, Rafael
    CLINICAL LUNG CANCER, 2019, 20 (03) : 167 - 177
  • [43] EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer
    Shih, JY
    Gow, CH
    Yang, PC
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 207 - 208
  • [44] EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer
    Kamel-Reid, S.
    Chong, G.
    Ionescu, D. N.
    Magliocco, A. M.
    Spatz, A.
    Tsao, M.
    Weng, X.
    Young, S.
    Zhang, T.
    Soulieres, D.
    CURRENT ONCOLOGY, 2012, 19 (02) : E67 - E74
  • [45] Predictive value of spectral computed tomography parameters for EGFR gene mutation in non-small-cell lung cancer
    Yu, Y.
    Han, C.
    Gan, X.
    Tian, W.
    Zhou, C.
    Zhou, Y.
    Xu, X.
    Wen, Z.
    Liu, W.
    CLINICAL RADIOLOGY, 2024, 79 (08) : e1049 - e1056
  • [46] Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives
    Haddad, Fady G.
    Kourie, Hampig R.
    Kattan, Joseph
    FUTURE ONCOLOGY, 2017, 13 (03) : 201 - 204
  • [47] Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer
    Nishii, Teppei
    Yokose, Tomoyuki
    Miyagi, Yohei
    Daigo, Yataro
    Ito, Hiroyuki
    Isaka, Tetsuya
    Imai, Kentaro
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Oshita, Fumihiro
    Yamada, Kouzo
    Matsukuma, Shoichi
    Tsuboi, Masahiro
    Nakayama, Haruhiko
    Masuda, Munetaka
    BMC CANCER, 2014, 14
  • [48] Epidermal Growth Factor Receptor (EGFR) and HER2 gene amplification predict response to gefitinib therapy in advanced non-small cell lung cancer (NSCLC)
    Cappuzzo, Federico
    Hirsch, Fred R.
    Rossi, Elisa
    Bartolini, Stefania
    Ceresoli, Giovanni-Luca
    Ludovini, Vienna
    Franklin, Wilbur A.
    Crino, Lucio
    Bunn, Paul A.
    Varella-Garcia, Marileila
    ANNALS OF ONCOLOGY, 2004, 15 : 166 - 166
  • [49] Characteristics and predictive modeling of HER2 mutation in patients with non-small cell lung cancer
    Varolgunes, Uras
    Mittal, Garima
    Parikh, Kaushal
    Ip, Andrew
    Malhotra, Jyoti
    Bates, Benjamin
    Salas, Maribel
    Arunachalam, Meena
    Chen, Haoqian
    Chen, Wenjin
    Yu, Dantong
    Setoguchi, Soko
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer
    Kim, Jung Soo
    Cho, Min Seong
    Nam, Jong Hyeon
    Kim, Hyun-Jung
    Choi, Kyeng-Won
    Ryu, Jeong-Seon
    PLOS ONE, 2017, 12 (05):
12345